Atlas Trials

A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants

Clinical trial NCT01436201 · COMPLETED

Trial details

NCT number
NCT01436201
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2011-09-01
Primary completion
2011-11-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.